[EN] CRYSTALLINE FORMS OF A PYRROLIDONE DERIVATIVE USEFUL IN THE TREATMENT OF ALZHEIMER'S DISEASE AND PREPARATION THEREOF<br/>[FR] FORMES CRISTALLINES D'UN DÉRIVÉ PYRROLIDONE UTILES DANS LE TRAITEMENT DE LA MALADIE D'ALZHEIMER ET PRÉPARATION DE CELLES-CI
申请人:HOFFMANN LA ROCHE
公开号:WO2015063001A1
公开(公告)日:2015-05-07
The present invention provides processes to manufacture crystalline N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxo-pyrrolidin-3-yl]acetamide. Also disclosed are polymorphic forms of said compound as well as compounds useful as intermediates in the methods of the invention.
[EN] PYRIDAZINE DERIVATIVES AS RORc MODULATORS<br/>[FR] DÉRIVÉS DE PYRIDAZINE EN TANT QUE MODULATEURS DE RORC
申请人:HOFFMANN LA ROCHE
公开号:WO2016177686A1
公开(公告)日:2016-11-10
Compounds of formula (I): or pharmaceutical salts thereof, wherein m, n, A, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of inflammatory diseases such as arthritis.
Method for preparing enantiomerically pure 4-pyrrolidinophenylbenzyl ether derivatives
申请人:Lohri Bruno
公开号:US20060211869A1
公开(公告)日:2006-09-21
The invention relates to a method for preparing enantiomerically pure 4-pyrrolidinophenylbenzyl ether derivatives of formula I:
wherein R
1
, R
21
, R
22
, R
23
, R
24
and n are as defined the description and claims and to intermediates and salts thereof useful in the method of the invention.